KLP Kapitalforvaltning AS bought a new position in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 1,500 shares of the industrial products company's stock, valued at approximately $367,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Charles Schwab Investment Management Inc. grew its stake in shares of UFP Technologies by 4.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 67,099 shares of the industrial products company's stock valued at $21,250,000 after purchasing an additional 2,842 shares during the period. FMR LLC grew its position in UFP Technologies by 54.6% during the third quarter. FMR LLC now owns 1,178 shares of the industrial products company's stock valued at $373,000 after buying an additional 416 shares during the period. BNP Paribas Financial Markets increased its holdings in UFP Technologies by 217.2% during the third quarter. BNP Paribas Financial Markets now owns 7,842 shares of the industrial products company's stock valued at $2,484,000 after buying an additional 5,370 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. grew its position in shares of UFP Technologies by 97.1% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 270 shares of the industrial products company's stock valued at $86,000 after acquiring an additional 133 shares during the period. Finally, Centiva Capital LP lifted its position in UFP Technologies by 65.2% during the third quarter. Centiva Capital LP now owns 2,580 shares of the industrial products company's stock valued at $817,000 after purchasing an additional 1,018 shares in the last quarter. Institutional investors own 87.28% of the company's stock.
Insider Transactions at UFP Technologies
In related news, Director Daniel C. Croteau sold 6,846 shares of the company's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $228.41, for a total transaction of $1,563,694.86. Following the sale, the director now owns 1,785 shares of the company's stock, valued at $407,711.85. This represents a 79.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 6.17% of the company's stock.
UFP Technologies Price Performance
UFPT stock traded down $6.34 during mid-day trading on Thursday, hitting $205.58. The company had a trading volume of 96,927 shares, compared to its average volume of 78,415. The company has a 50-day moving average price of $226.36 and a 200 day moving average price of $264.12. UFP Technologies, Inc. has a 12-month low of $178.26 and a 12-month high of $366.41. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of 29.33 and a beta of 1.08. The company has a quick ratio of 1.43, a current ratio of 2.57 and a debt-to-equity ratio of 0.64.
UFP Technologies (NASDAQ:UFPT - Get Free Report) last posted its earnings results on Tuesday, February 25th. The industrial products company reported $2.46 EPS for the quarter, topping analysts' consensus estimates of $2.01 by $0.45. The company had revenue of $144.07 million for the quarter, compared to the consensus estimate of $141.67 million. UFP Technologies had a return on equity of 18.92% and a net margin of 11.74%.
Analyst Ratings Changes
UFPT has been the subject of several analyst reports. Raymond James initiated coverage on shares of UFP Technologies in a report on Friday, March 28th. They issued a "market perform" rating for the company. StockNews.com downgraded UFP Technologies from a "hold" rating to a "sell" rating in a research note on Thursday, January 23rd.
Read Our Latest Stock Analysis on UFP Technologies
UFP Technologies Profile
(
Free Report)
UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.
See Also
Before you consider UFP Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UFP Technologies wasn't on the list.
While UFP Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
